A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021.
- DOI
- 10.1128/aac.00349-23
- Published
- 2023-09-20
- Container
- Antimicrob Agents Chemother
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.00349-23,
title = {A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021.},
author = {Snydman DR and McDermott LA and Thorpe CM and Goldstein EJC and Schuetz AN and Johnson S and Gerding DN and Gluck L and Bourdas D and Carroll KC and Lancaster CK and Garey KW and Wang Q and Walk ST and Duperchy E.},
year = {2023},
journal = {Antimicrob Agents Chemother},
doi = {10.1128/aac.00349-23},
url = {https://doi.org/10.1128/aac.00349-23}
}RIS
TY - JOUR TI - A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021. AU - Snydman DR AU - McDermott LA AU - Thorpe CM AU - Goldstein EJC AU - Schuetz AN AU - Johnson S AU - Gerding DN AU - Gluck L AU - Bourdas D AU - Carroll KC AU - Lancaster CK AU - Garey KW AU - Wang Q AU - Walk ST AU - Duperchy E. PY - 2023 JO - Antimicrob Agents Chemother DO - 10.1128/aac.00349-23 UR - https://doi.org/10.1128/aac.00349-23 ER -
APA
DR, S., LA, M., CM, T., EJC, G., AN, S., S, J., DN, G., L, G., D, B., KC, C., CK, L., KW, G., Q, W., ST, W., & E., D. (2023). A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021.. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.00349-23
Source records
- europe-pmc · retrieved 2026-09-26T19:34:31.672Z